Effects of vaccination and the new neuraminidase inhibitor, laninamivir, on influenza infection.
<h4>Background</h4>Evidence of the effectiveness of influenza vaccination in children and elderly adults is limited, although this population has the highest risk for influenza infection.<h4>Materials and methods</h4>We enrolled 4443 participants, aged 3-97 years, who had inf...
Saved in:
| Main Authors: | Takuro Mizuno, Shigeru Mizuno, Tsugiyasu Kanda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0092601&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients
by: Toshiyuki Hikita, et al.
Published: (2012-01-01) -
Discovering Influenza Virus Neuraminidase Inhibitors via Computational and Experimental Studies
by: Trung Hai Nguyen, et al.
Published: (2024-11-01) -
Formulation development of a stable influenza recombinant neuraminidase vaccine candidate
by: Bing Li, et al.
Published: (2024-12-01) -
Neuraminidase Antibody Response to Homologous and Drifted Influenza A Viruses After Immunization with Seasonal Influenza Vaccines
by: Yulia Desheva, et al.
Published: (2024-11-01) -
Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase
by: Amanda K. Rudman Spergel, et al.
Published: (2025-07-01)